PATENT CLAIM ANALYSIS

Application Number: 16007047
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.

Claim (Index 20):
The pharmaceutical composition according to  claim 1 , in which the pharmaceutical composition is a mono-layer tablet, wherein:\n the percentage of metformin hydrochloride is about 85% by weight of total tablet core, the percentage of DPP-4 inhibitor is about 0.2% -0.4% by weight of total tablet core, the percentage of L-arginine is about 2% by weight of total tablet core, the tablet crushing strength is higher than or equal to 100 N, the tablet friability is lower than or equal to 0.5%, the tablet thickness is from about 5.7 to about 8.4 mm, the tablet core weight is from about 590 to about 1180 mg, and/or the tablet disintegration time is lower than or equal 15 min.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14836996', '12935634', '12894385', '13785365', '14294630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604172887021092
- 35 USC 102 Novelty (BERT): 0.6288950092413107
- Combined Prediction Score: 0.7472650607560294
- Mean Citation Score: 434.15789000000007
- Max Citation Score: 601.3611
- Similarity Product: 543.088357414484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test